Quest Diagnostics authorises stock split:
This article was originally published in Clinica
Executive Summary
Quest Diagnostics' board has approved a two-for-one stock split, which is expected to make the company's common shares more attractive, the Teterboro, New Jersey-based company says. Quest claims to be the leading US provider of diagnostic testing, information and services.